A UK ruling that Eli Lilly breached industry Code of Practice for a press release and new Australian guidance on media coverage for medicines underscore how media engagement could breach drug advertising rules if perceived as promotional.
A UK ruling that Eli Lilly breached industry Code of Practice for a press release and new Australian guidance on media coverage for medicines underscore how media engagement could breach drug advertising rules if perceived as promotional.